Published in Thyroid on August 08, 2012
A panel of four genes accurately differentiates benign from malignant thyroid nodules. J Exp Clin Cancer Res (2016) 1.40
Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer (2014) 0.93
The Mcgill thyroid nodule score - does it help with indeterminate thyroid nodules? J Otolaryngol Head Neck Surg (2015) 0.82
Translational research in endocrine surgery. Surg Oncol Clin N Am (2013) 0.81
The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes. BMC Bioinformatics (2016) 0.79
Potential effects of molecular testing of indeterminate thyroid nodule fine needle aspiration biopsy on thyroidectomy volume. World J Surg (2014) 0.79
Differentiation of benign from malignant thyroid nodules with acoustic radiation force impulse technique. Br J Radiol (2014) 0.79
Use of the afirma® gene expression classifier for preoperative identification of benign thyroid nodules with indeterminate fine needle aspiration cytopathology. PLoS Curr (2013) 0.78
Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur J Nucl Med Mol Imaging (2015) 0.77
Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears. J Clin Pathol (2016) 0.76
A benign genomic classifier for thyroid nodules with indeterminate cytology: a critical appraisal. Gland Surg (2012) 0.75
Materiomics for Oral Disease Diagnostics and Personal Health Monitoring: Designer Biomaterials for the Next Generation Biomarkers. OMICS (2016) 0.75
Decisional conflict in patients considering diagnostic thyroidectomy with indeterminate fine needle aspirate cytopathology. J Otolaryngol Head Neck Surg (2016) 0.75
Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making. Mol Imaging Radionucl Ther (2016) 0.75
Thyroid in 2012: Advances in thyroid development, hormone action and neoplasia. Nat Rev Endocrinol (2013) 0.75
The first Canadian experience with the Afirma® gene expression classifier test. J Otolaryngol Head Neck Surg (2017) 0.75
Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics. Diagn Pathol (2017) 0.75
A Pragmatic Approach to the Indeterminate Thyroid Nodule. Indian J Endocrinol Metab (2017) 0.75
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics. Eur Thyroid J (2017) 0.75
Determining Patient Preferences for Indeterminate Thyroid Nodules: Observation, Surgery or Molecular Tests. World J Surg (2017) 0.75
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
Management of a solitary thyroid nodule. N Engl J Med (1993) 7.15
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med (2012) 7.06
The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol (2009) 6.79
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med (2009) 5.69
Clinical practice. The thyroid nodule. N Engl J Med (2004) 4.84
Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med (1993) 4.09
Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer (2007) 3.36
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest (2010) 2.20
A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid (2010) 1.68
Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab (2010) 1.57
Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol (2008) 1.39
A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid (2008) 1.27
Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab (2011) 1.24
Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery (2007) 1.18
Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. Arch Otolaryngol Head Neck Surg (2008) 1.08
Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol (2002) 1.08
Rehospitalization among elderly patients with thyroid cancer after thyroidectomy are prevalent and costly. Ann Surg Oncol (2010) 1.07
Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery (2008) 1.04
Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery (1989) 0.94
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2006) 12.23
A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res (2005) 11.02
Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods (2004) 9.52
Mapping human genetic diversity in Asia. Science (2009) 7.40
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med (2012) 7.06
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab (2008) 5.94
Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res (2004) 5.59
Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics (2005) 5.01
Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet (2004) 4.76
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. Lancet Oncol (2010) 3.75
A second-generation combined linkage physical map of the human genome. Genome Res (2007) 3.60
The genomic distribution of population substructure in four populations using 8,525 autosomal SNPs. Hum Genomics (2004) 3.53
Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet (2006) 3.29
Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab (2009) 3.23
Description of the data from the Collaborative Study on the Genetics of Alcoholism (COGA) and single-nucleotide polymorphism genotyping for Genetic Analysis Workshop 14. BMC Genet (2005) 3.04
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg (2002) 2.68
Algorithms for large-scale genotyping microarrays. Bioinformatics (2003) 2.66
High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. Am J Hum Genet (2005) 2.39
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery (2008) 2.23
Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery (2013) 1.85
Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR. BMC Mol Biol (2008) 1.81
A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid (2010) 1.68
Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules. J Clin Endocrinol Metab (2012) 1.60
Prevalence of thyroid cancer in multinodular goiter versus single nodule: a systematic review and meta-analysis. Thyroid (2013) 1.59
Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab (2010) 1.57
Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. Thyroid (2010) 1.43
An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. J Mol Diagn (2006) 1.40
Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008. Thyroid (2011) 1.26
Massively parallel pathogen identification using high-density microarrays. Microb Biotechnol (2008) 1.26
Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target. J Clin Endocrinol Metab (2010) 1.25
Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids. J Clin Endocrinol Metab (2004) 1.22
Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer. J Clin Endocrinol Metab (2012) 1.21
The PAX8/PPARgamma fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARgamma inhibition. Oncogene (2004) 1.20
A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med (2013) 1.19
A whole genome long-range haplotype (WGLRH) test for detecting imprints of positive selection in human populations. Bioinformatics (2006) 1.17
Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth. Cancer Res (2009) 1.16
Application of broad-spectrum resequencing microarray for genotyping rhabdoviruses. J Virol (2010) 1.16
Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J Clin Endocrinol Metab (2010) 1.13
Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysis. Arthritis Rheum (2009) 1.09
The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer. Mol Cell Endocrinol (2009) 1.07
Comparison of single-nucleotide polymorphisms and microsatellite markers for linkage analysis in the COGA and simulated data sets for Genetic Analysis Workshop 14: Presentation Groups 1, 2, and 3. Genet Epidemiol (2005) 1.07
Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis. Mod Pathol (2002) 1.07
Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn (2002) 1.04
The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study. J Am Coll Cardiol (2006) 1.03
Paternal origins of complete hydatidiform moles proven by whole genome single-nucleotide polymorphism haplotyping. Genomics (2002) 1.01
Patterns of care in community-based oncology practices for anemia associated with myelosuppressive chemotherapy. J Oncol Pract (2009) 0.98
Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules? J Clin Endocrinol Metab (2013) 0.98
PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. J Clin Endocrinol Metab (2004) 0.97
Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status. J Clin Endocrinol Metab (2009) 0.95
Consumptive hypothyroidism resulting from hepatic vascular tumors in an athyreotic adult. J Clin Endocrinol Metab (2011) 0.95
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis. Endocrinology (2006) 0.88
Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism. Thyroid (2010) 0.87
Effects of reducing the upper limit of normal TSH values. JAMA (2003) 0.87
RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma. J Clin Endocrinol Metab (2013) 0.86
The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer. PPAR Res (2008) 0.86
Use of consensus sequences for the design of high density resequencing microarrays: the influenza virus paradigm. BMC Genomics (2010) 0.86
Rosai-Dorfman disease of the thyroid masquerading as anaplastic carcinoma. Thyroid (2003) 0.85
Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis. Clin Chem (2010) 0.85
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H. J Clin Endocrinol Metab (2014) 0.83
Reconstructed ancestral sequences improve pathogen identification using resequencing DNA microarrays. PLoS One (2010) 0.83
Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology (2010) 0.83
High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. J Clin Endocrinol Metab (2002) 0.81
The Putative PAX8/PPARγ Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARγ Activity. Genes Cancer (2011) 0.81
Application of high-density DNA resequencing microarray for detection and characterization of botulinum neurotoxin-producing clostridia. PLoS One (2013) 0.80
Is there a role for radiation therapy in the management of Hürthle cell carcinoma? Int J Radiat Oncol Biol Phys (2003) 0.80
A genome-wide linkage analysis of alcoholism on microsatellite and single-nucleotide polymorphism data, using alcohol dependence phenotypes and electroencephalogram measures. BMC Genet (2005) 0.79
Open-target sparse sensing of biological agents using DNA microarray. BMC Bioinformatics (2011) 0.78
Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. J Clin Endocrinol Metab (2003) 0.78
A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the mayo clinic experience. Rare Tumors (2013) 0.78
A novel dynamin III isoform is up-regulated in the central nervous system in hypothyroidism. Int J Dev Neurosci (2003) 0.77
Summary of proceedings of the second World Congress on Thyroid Cancer. Head Neck (2014) 0.77
Molecular Assays in Cytopathology for Thyroid Cancer. Cancer Control (2015) 0.76
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract (2012) 0.76
Machine learning from concept to clinic: reliable detection of BRAF V600e DNA mutations in thyroid nodules using high-dimensional RNA expression data. Pac Symp Biocomput (2015) 0.76
Optimising restriction enzyme cleavage of DNA derived from archival histopathological samples: an improved HUMARA assay. Pathology (2003) 0.75
Analysis of SNP content of 82 common copy-number polymorphisms from the Database of Genomic Variations. Am J Hum Genet (2006) 0.75
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care (2012) 0.75
Prognostic factors for thyroid carcinoma originating from follicular cells. J Thyroid Res (2011) 0.75
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: TIMING OF MULTIPLE ENDOCRINE NEOPLASIA THYROIDECTOMY AND EXTENT OF CENTRAL NECK LYMPHADENECTOMY. Endocr Pract (2015) 0.75